Novel Capture and Detection of Viable Bacteria from Whole Blood
- Caryn Tyler
- Jul 7
- 1 min read
Bloodstream infections, such as sepsis, demand rapid and accurate pathogen detection and identification. Conventional blood culture methods are hindered by lengthy incubation times and the requirement for large sample volumes, which limits their utility in critically ill patients. Although molecular assays offer faster turnaround, they are often compromised by high background levels of host DNA, low pathogen titers, and an inability to isolate intact organisms for downstream culturing applications.
This study aims to address two key questions:
Do Nanotrap® Microbiome B Particles improve the detection sensitivity of bacteria from whole blood relative to current standard extraction methods?
Can Nanotrap Microbiome B Particles capture and concentrate gram-positive and gram-negative bacteria from whole blood?
SKU# 65XXX
Literature # BL-PO31447